Ofatumumab in combination with high-dose methylprednisolone for the treatment of patients with relapsed or refractory chronic lymphocytic leukemia.

被引：0
|
作者：
Castro, Januario E. [1 ]
Choi, Michael Y. [1 ]
Carvajal, Tomas [1 ]
Li, Hongying [1 ]
James, Danelle Frances [1 ]
Messer, Karen [1 ]
Kipps, Thomas J. [1 ]
机构：
[1] UC San Diego Moores Canc Ctr, La Jolla, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7124
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Ofatumumab and high-dose methylprednisolone for the treatment of patients with relapsed or refractory chronic lymphocytic leukemia
    Castro, J. E.
    Choi, M. Y.
    Carvajal, T.
    Almahasnah, E.
    Chang, J.
    James, D. F.
    Kipps, T. J.
    [J]. BLOOD CANCER JOURNAL, 2014, 4 : e258 - e258
  • [2] Ofatumumab and high-dose methylprednisolone for the treatment of patients with relapsed or refractory chronic lymphocytic leukemia
    J E Castro
    M Y Choi
    T Carvajal
    E Almahasnah
    J Chang
    D F James
    T J Kipps
    [J]. Blood Cancer Journal, 2014, 4 : e258 - e258
  • [3] Rituximab® and high dose methylprednisolone (HDMP) for the treatment of patients with relapsed/refractory chronic lymphocytic leukemia.
    Castro, JE
    Bole, J
    Prada, CE
    Kipps, TJ
    [J]. BLOOD, 2004, 104 (11) : 690A - 690A
  • [4] Combined Rituximab and high-dose methylprednisolone for the treatment of chronic lymphocytic leukemia.
    Bole, J
    Yan, L
    Tsukada, N
    Kipps, TJ
    [J]. BLOOD, 2002, 100 (11) : 802A - 802A
  • [5] Rituximab in combination with high-dose dexamethasone for the treatment of relapsed/refractory chronic lymphocytic leukemia
    Smolej, Lukas
    Doubek, Michael
    Panovska, Anna
    Simkovic, Martin
    Brychtova, Yvona
    Belada, David
    Motyckova, Monika
    Mayer, Jiri
    [J]. LEUKEMIA RESEARCH, 2012, 36 (10) : 1278 - 1282
  • [6] Rituximab in combination with high-dose methylprednisolone for the treatment of chronic lymphocytic leukemia
    Castro, J. E.
    James, D. F.
    Sandoval-Sus, J. D.
    Jain, S.
    Bole, J.
    Rassenti, L.
    Kipps, T. J.
    [J]. LEUKEMIA, 2009, 23 (10) : 1779 - 1789
  • [7] Rituximab in combination with high-dose methylprednisolone for the treatment of chronic lymphocytic leukemia
    J E Castro
    D F James
    J D Sandoval-Sus
    S Jain
    J Bole
    L Rassenti
    T J Kipps
    [J]. Leukemia, 2009, 23 : 1779 - 1789
  • [8] RITUXIMAB IN COMBINATION WITH HIGH-DOSE DEXAMETHASONE: AN EFFECTIVE TREATMENT OPTION FOR PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA
    Simkovic, M.
    Panovska, A.
    Belada, D.
    Hrudkova, M.
    Brychtova, Y.
    Mayer, J.
    Smolej, L.
    Doubek, M.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 326 - 326
  • [9] Dose-dense high-dose methylprednisolone and rituximab in the treatment of relapsed or refractory high-risk chronic lymphocytic leukemia
    Pileckyte, Regina
    Jurgutis, Mindaugas
    Valceckiene, Vilma
    Stoskus, Mindaugas
    Gineikiene, Egle
    Sejoniene, Jurgita
    Degulys, Andrius
    Zvirblis, Tadas
    Griskevicius, Laimonas
    [J]. LEUKEMIA & LYMPHOMA, 2011, 52 (06) : 1055 - 1065
  • [10] Rituximab in combination with high-dose methylprednisolone for the treatment of fludarabine refractory high-risk chronic lymphocytic leukemia
    Castro, J. E.
    Sandoval-Sus, J. D.
    Bole, J.
    Rassenti, L.
    Kipps, T. J.
    [J]. LEUKEMIA, 2008, 22 (11) : 2048 - 2053
12345